These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24963116)

  • 1. Comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062.
    Carr RD; Alexander CM
    Diabetes Care; 2014 Jul; 37(7):e161-2. PubMed ID: 24963116
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062.
    Monnier L; Colette C; Dejager S; Owens D
    Diabetes Care; 2014 Jul; 37(7):e163. PubMed ID: 24963117
    [No Abstract]   [Full Text] [Related]  

  • 3. Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes.
    Porcellati F; Lucidi P; Bolli GB; Fanelli CG
    Diabetes Care; 2013 Dec; 36(12):3860-2. PubMed ID: 24265365
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?
    Monnier L; Colette C; Dejager S; Owens D
    Diabetes Care; 2013 Dec; 36(12):4057-62. PubMed ID: 24170753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570.
    Garvey WT; Cohen RM
    Diabetes Care; 2024 Sep; 47(9):e72-e73. PubMed ID: 39190926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Typ 2 diabetes: glucose centered therapy is obsolete].
    Reincke M; Seissler J
    MMW Fortschr Med; 2008 May; 150(18):26-7. PubMed ID: 18533604
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comment from the diabetology viewpoint].
    Stahl M
    Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycosylated haemoglobin: its correlation with blood sugar in management of maturity onset diabetes mellitus.
    Juneja SC; Ohri VC; Bhalla IP; Singh B; Sindhi JC; Rastogi DS
    J Assoc Physicians India; 1984 Sep; 32(9):785-8. PubMed ID: 6511766
    [No Abstract]   [Full Text] [Related]  

  • 9. HbA(1c) and glycemic profile, basal- and post-treatment with Miglitol, in an area with a Mediterranean diet.
    Faure E; Pallardo LF; Mesa J; Puig-Domingo M; García-Mayor R; Benito P; Ravella R; Artés M; López JS;
    Diabetes Care; 2002 Oct; 25(10):1896-8. PubMed ID: 12351510
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy.
    Mukherjee JJ; Majumdar S; Ray S
    J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486
    [No Abstract]   [Full Text] [Related]  

  • 11. [New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines].
    Adler AI; Shaw EJ; Stokes T; Ruiz F
    Praxis (Bern 1994); 2009 Oct; 98(20):1161-3. PubMed ID: 19809980
    [No Abstract]   [Full Text] [Related]  

  • 12. New insights into the older hypoglycemic agents in type 2 diabetes therapy.
    Cao M; Bloomgarden Z
    J Diabetes; 2020 Nov; 12(11):844-847. PubMed ID: 32767624
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective EHR-based clinical trials: the challenge of missing data.
    Kharrazi H; Wang C; Scharfstein D
    J Gen Intern Med; 2014 Jul; 29(7):976-8. PubMed ID: 24839057
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical practice. Glycemic management of type 2 diabetes mellitus.
    Ismail-Beigi F
    N Engl J Med; 2012 Apr; 366(14):1319-27. PubMed ID: 22475595
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intensive blood glucose reduction: yes or no?].
    Bischoff A
    MMW Fortschr Med; 2015 Mar; 157(4):18-9. PubMed ID: 25743962
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of glycemic control.
    Shahady EJ
    J Fam Pract; 2011 Sep; 60(9 Suppl):S4-6. PubMed ID: 21912776
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 18. Daily glycaemic variability: benefits of optimal control.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():1-2. PubMed ID: 24034512
    [No Abstract]   [Full Text] [Related]  

  • 19. Home glucose monitoring makes little difference in type 2 diabetes.
    J Fam Pract; 2005 Nov; 54(11):936. PubMed ID: 16299946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of diabetes mellitus].
    Daweke H
    Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.